SCHEMBL4710117

SCHEMBL4710117

COC(=O)c1cccc(/C=C/c2ccccc2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
CYP2C19 P33261 3/20 0.56
CYP1A2 P05177 3/20 0.56
POLB P06746 2/20 0.56
HSD17B10 Q99714 1/20 0.56
ALDH1A1 P00352 5/20 0.53
GRM4 Q14833 4/20 0.53
HPGD P15428 4/20 0.53
KDM4E B2RXH2 4/20 0.53
KMT2A Q03164 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
MEN1 O00255 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2C9 P11712 2/20 0.53
GRM5 P41594 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
CYP2D6 P10635 1/20 0.53
PKM P14618 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710118 1.00 NPC1 (0.56) NPC1RAB9ACYP2C19CYP1A2POLB
SCHEMBL22939705 0.85 ALDH1A1 (0.50) NPC1RAB9ACYP2C19CYP1A2POLB
SCHEMBL28816836 0.85 L3MBTL1 (0.49) NPC1RAB9APOLBALDH1A1HPGD
SCHEMBL9000431 0.84 MAPT (0.46) NPC1RAB9ACYP2C19CYP1A2POLB
SCHEMBL4711172 0.83 GRM4 (0.57) NPC1RAB9ACYP2C19ALDH1A1GRM4
SCHEMBL4711170 0.83 GRM4 (0.57) NPC1RAB9ACYP2C19ALDH1A1GRM4
SCHEMBL2597810 0.82 GRM4 (0.61) NPC1RAB9ACYP2C19CYP1A2POLB
SCHEMBL2597811 0.82 GRM4 (0.61) NPC1RAB9ACYP2C19CYP1A2POLB
SCHEMBL4713611 0.80 GRM4 (0.62) NPC1RAB9ACYP2C19ALDH1A1GRM4
SCHEMBL4713613 0.80 GRM4 (0.62) NPC1RAB9ACYP2C19ALDH1A1GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed